Dr Glen Reid
Senior Lecturer of the ADRI
Asbestos Diseases Research Institute
As Senior Research Scientist at the Asbestos Diseases Research Insitute I lead research focused on translational studies of malignant pleural mesothelioma, an asbestos-related cancer for which Australia has one of the worlds highest incidence rates. My research aims to identify new molecular biomarkers and novel therapeutic targets for this disease.
Current national competitive grants*
The use of RNAi to identify new therapeutic targets for malignant mesothelioma
Cancer Australia Priority-driven Collaborative Cancer Research Scheme ($374,229 over 3 years)
* Grants administered through the University of Sydney